Evidence map›Paper›PMID 40694511›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Importance of Targeted Communication Strategies During COVID-19 Vaccination Campaigns in Mozambique: Results of a Mixed-Methods Acceptability Study.

Caroline De Schacht, Igor Ubisse Capitine, Carlota Lucas, Ana Muteerwa, Paula Paulo, Alvaro Manhiça, Fernando Padama, Celso Belo, Leonildo Nhampossa, Graça Matsinhe and 2 more

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Caroline De SchachtCentro Pela Saúde Global (C-Saúde), Evaluations Department, Maputo, Mozambique.ORCID 0000-0001-5384-2410
Igor Ubisse CapitineInstituto Nacional de Saúde, Maputo, Mozambique.
Carlota LucasCentro Pela Saúde Global (C-Saúde), Evaluations Department, Maputo, Mozambique.
Ana MuteerwaUS Centers for Disease Control and Prevention, Division of Global HIV and TB, Maputo, Mozambique.
Paula PauloCentro Pela Saúde Global (C-Saúde), Evaluations Department, Maputo, Mozambique.
Alvaro ManhiçaInstituto Nacional de Saúde, Maputo, Mozambique.
Fernando PadamaProvincial Health Directorate of Zambézia, Operations Research Unit, Quelimane, Mozambique.
Celso BeloCentro Pela Saúde Global (C-Saúde), Evaluations Department, Maputo, Mozambique.ORCID 0000-0001-6122-6861
Leonildo NhampossaMinistry of Health, National Directorate of Public Health, Maputo, Mozambique.
Graça MatsinheMinistry of Health, National Directorate of Public Health, Maputo, Mozambique.
Zhihong YuVanderbilt University Medical Center (VUMC), Department of Biostatistics, Nashville, Tennessee, USA.
C William WesterVanderbilt University Medical Center (VUMC), Vanderbilt Institute for Global Health (VIGH), Nashville, Tennessee, USA.ORCID 0000-0002-8375-3926

Funding

CGH CDC HHS R43 GH002367Coronavirus Aid, Relief, and Economic SecurityUSAID Contracts for Implementing PartnersUS Centers for Disease Control and Prevention U2GGH002367
6 · The paper itself

Abstract

backgroundMozambique implemented a phased roll-out of COVID-19 vaccination in 2021. This study aimed to evaluate COVID-19 vaccine acceptability among higher-risk populations in Zambézia Province.

methodsA mixed-methods study in Zambézia Province assessed knowledge, perceptions, and acceptability of COVID-19 vaccination. Structured questionnaire-based surveys among community health workers/volunteers, taxi drivers, and persons with HIV; and focus group discussions using semi-structured guides with community/religious leaders, adults aged 18-49 years and adults aged 50+ years were conducted in August-September 2021. Surveys were captured using tablets; group discussions were recorded. Univariate analyses were performed for quantitative data; qualitative data were analyzed thematically.

resultsA total of 731 individuals participated (539 survey respondents; 192 discussion respondents); 53% male (n = 386) and 74% urban (n = 544) residents. Most had heard about COVID-19 vaccines, mainly through television and/or radio. Trustworthy information sources mentioned were community leaders and healthcare providers. Among survey respondents, 249/539 (46%) reported having received at least 1 vaccine dose. Motivators for vaccination mentioned by survey respondents were "belief that vaccines protect themselves" (72%), "belief it would protect their family" (17%). Myths and beliefs, misinformation, and long queues were main barriers for vaccination mentioned in group discussions. Participants suggested that campaigns should focus on communication talks led by health professionals, in partnership with community or church leaders and/or community health workers/volunteers.

conclusionsThis study showed that information on COVID-19 vaccination had successfully reached the vast majority of study participants, mainly via radio and television. Targeted campaigns specific for rural and urban contexts can increase awareness and uptake of vaccination.

Indexed as

CommunicationCOVID-19COVID-19 VaccinesImmunization ProgramsPatient Acceptance of Health CareVaccinationAdolescentAdultAgedFemaleFocus GroupsHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedMozambiqueCOVID-19 Vaccinesacceptabilitycommunication strategiesCOVID-19 vaccinationMozambique

Identifiers

PMID40694511
PMCPMC12282518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.